Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Anti-inflammatory agent 52 (compound 7j) is an orally active, selective COX-2 inhibitor with the capability to induce G2/M phase arrest and exhibit anti-HT29 transfer activity. It demonstrates moderate anti-inflammatory efficacy and a notable safety profile. Additionally, this compound possesses the uncommon ability to inhibit tumor growth in mouse models, indicative of its anticancer properties [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | Anti-inflammatory agent 52 (compound 7j) is an orally active, selective COX-2 inhibitor with the capability to induce G2/M phase arrest and exhibit anti-HT29 transfer activity. It demonstrates moderate anti-inflammatory efficacy and a notable safety profile. Additionally, this compound possesses the uncommon ability to inhibit tumor growth in mouse models, indicative of its anticancer properties [1]. |
In vitro | Anti-inflammatory agent 52 (compound 7j) at a concentration of 0.25 μM over 24 hours inhibits colony formation in HT29 cells and induces cell cycle arrest at the G2/M phase [1]. |
In vivo | Anti-inflammatory agent 52, also known as compound 7j, at a dosage of 50 mg/kg administered orally every other day for two weeks, was found to reduce tumor volume and weight in mice with Ehrlich solid carcinoma [1]. |
Molecular Weight | 452.95 |
Formula | C24H21ClN2O3S |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Anti-inflammatory agent 52 Immunology/Inflammation Neuroscience COX inhibitor inhibit